A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma
PHASE3
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHalerĀ® 2, and SereventĀ® DiskusĀ® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
PHASE2
The primary objective of this trial was to establish non-inferiority of lun...
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
PHASE2
The primary objective of this study is to evaluate the dose response, effic...